Showing results (461-470 of 472) with videos related to

Sort By:
Pageof 48
Journal of Biophotonics|February 6, 2019
Multi-ATOM: Ultrahigh-throughput single-cell quantitative phase imaging with subcellular resolutionKelvin C M Lee, Andy K S Lau, Anson H L Tang, et al.
Journal of Ethnopharmacology|February 13, 2001
Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxisT Y Shin, H J Jeong, D K Kim, et al.
Journal of Viral Hepatitis|August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3S Pianko, S Zeuzem, W-L Chuang, et al.
Lab on a Chip|September 16, 2020
Deep-learning-assisted biophysical imaging cytometry at massive throughput delineates cell population heterogeneityDickson M D Siu, Kelvin C M Lee, Michelle C K Lo, et al.
Science Advances|June 5, 2020
CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cellsM Goodwin, E Lee, U Lakshmanan, et al.
Journal of Viral Hepatitis|March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinG R Foster, S Zeuzem, S Pianko, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.
JAMA Neurology|January 9, 2023
Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients: The Stentrode With Thought-Controlled Digital Switch (SWITCH) StudyPeter Mitchell, Sarah C M Lee, Peter E Yoo, et al.
Redox Biology|January 14, 2023
Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patientsK A Mapuskar, G Vasquez Martinez, C F Pulliam, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis BP Marcellin, S H Ahn, W-L Chuang, et al.
Pageof 48